The use of unnecessary radiotherapy in patients with metastatic cancer who are near the end of life is still far higher than guidelines suggest it should be, concludes a nationally comprehensive database study. It underscores the need for better adherence to the guidelines, say the authors. The study was published online January 14 in JAMA Health Forum. MSK’s Patricia Santos and Erin Gillespie are quoted.